NCT03622060View on ClinicalTrials.gov

Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

May 21, 2019

Study Completion Date

May 22, 2019

Conditions
Radial Artery Injury at Wrist and Hand LevelOcclusion of ArteryVasodilation
Interventions
DRUG

Nitroglycerin

200 microgram intraarterial nicardipine and 500 microgram nitroglycerin administered before sheath removal

Trial Locations (1)

10630

Hermina Heart Center, Jakarta Pusat

All Listed Sponsors
collaborator

Hermina Hospital Group

UNKNOWN

lead

Hermina Heart Center Kemayoran

OTHER

NCT03622060 - Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion | Biotech Hunter | Biotech Hunter